2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. … Read more

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care … Read more

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company’s … Read more

Medical supply firm Medline jumps more than 30% in debut after biggest IPO of 2025

Medical supply firm Medline jumps more than 30% in debut after biggest IPO of 2025

Shares of U.S. medical supplies giant Medline jumped more than 30% in its debut on the Nasdaq on Wednesday after the biggest initial public offering of the year globally. The stock opened at $35, up from its $29 IPO price. The private equity-owned company sold a little over 216 million shares on Tuesday, raising $6.26 … Read more

Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial  

Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial  

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Thursday said its next-generation obesity drug delivered what appears to be the highest weight loss yet in a late-stage trial while reducing knee arthritis pain, clearing the first of several upcoming … Read more

‘Terrifying’: Why U.S. senator in top intel post wants more spying on Chinese companies

‘Terrifying’: Why U.S. senator in top intel post wants more spying on Chinese companies

Go back a decade and most Americans had never heard of Huawei. Today, the Chinese telecom giant is a symbol of how quickly China can dominate a strategic technology sector and in the process create new national security and market threats for U.S. government and industry. Democratic Senator Mark Warner of Virginia, the top Democrat … Read more

RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies until Friday

RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies until Friday

Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine committee on Thursday deferred crucial votes on hepatitis B vaccines for babies until Friday, saying it will give members more time to review proposed language on the measure. One panel member, Dr. Cody Meissner, a professor of pediatrics at the Dartmouth Geisel School of … Read more

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the … Read more

Eli Lilly hits $1 trillion market value, a first for a health-care company

Eli Lilly hits  trillion market value, a first for a health-care company

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly reached a $1 trillion market capitalization on Friday, the first health-care company in the world to join the exclusive club dominated by tech firms.  Eli Lilly briefly hit … Read more